Keratin disorders: From gene to therapy

Human Molecular Genetics

Volumn 20, Issue R2, 2011, Pages 189-197

  Irwin McLean, W H ^a   Moore, C B ^a,b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 16; CYTOKERATIN 17; CYTOKERATIN 6; DOUBLE STRANDED RNA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; POLYACRYLAMIDE; RETINOID; SMALL INTERFERING RNA; SULFORAPHANE; KERATIN;

ALLELE; ALOPECIA; ARTICLE; BLISTER; CLINICAL TRIAL (TOPIC); CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; CORNEA; CYTOSKELETON; DISEASE SEVERITY; ECTODERMAL DYSPLASIA; ENTERITIS; EPIDERMOLYSIS BULLOSA SIMPLEX; EPIDERMOLYTIC PALMOPLANTAR KERATODERMA; EPITHELIUM; EPITHELIUM BASAL CELL; GENE EXPRESSION; GENE SILENCING; GENE THERAPY; GENETIC DISORDER; GOOD MANUFACTURING PRACTICE; HAIR; HEREDITY; HUMAN; HYPERKERATOSIS; ICHTHYOSIS BULLOSA OF SIEMENS; IN VIVO STUDY; INDEL MUTATION; KERATIN DISORDER; LEUKOPLAKIA; LOW DRUG DOSE; MECHANICAL STRESS; MEESMANN CORNEAL DYSTROPHY; MISSENSE MUTATION; MONILETHRIX; NONHUMAN; OXIDATIVE STRESS; PACHYONYCHIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN STRUCTURE; RNA INTERFERENCE; SKIN APPENDAGE DISEASE; SKIN FRAGILITY; SKIN PIGMENTATION; WHITE SPONGE NEVUS; WOUND HEALING; ANIMAL; GENETICS; HAIR DISEASE; METABOLISM; MUTATION; REVIEW;

MAMMALIA;

ANIMALS; ECTODERMAL DYSPLASIA; GENE THERAPY; HAIR DISEASES; HUMANS; KERATINS; MUTATION; RNA, SMALL INTERFERING;

EID: 83155181586     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr379     Document Type: Article

References (42)

1. Lane, E.B. (1993) Keratins. In Royce, P.M. and Steinmann, B. (eds), Connective Tissue and its Heritable Disorders. Molecular, Genetic and Medical Aspects. Wiley-Liss Inc, New York, pp. 237-247.
2. McLean, W.H.I. and Lane, E.B. (1995) Intermediate filaments in disease. Curr. Opin. Cell Biol., 7, 118-125.
3. Schweizer, J., Bowden, P.E., Coulombe, P.A., Langbein, L., Lane, E.B., Magin, T.M., Maltais, L., Omary, M.B., Parry, D.A., Rogers, M.A. et al. (2006) New consensus nomenclature for mammalian keratins. J. Cell Biol., 174, 169-174.
4. Lane, E.B. and Alexander, C.M. (1990) Use of keratin antibodies in tumor diagnosis. Semin. Cancer Biol., 1, 165-179.
5. Vassar, R., Coulombe, P.A., Degenstein, L., Albers, K. and Fuchs, E. (1991) Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease. Cell, 64, 365-380.
6. Fuchs, E. and Cleveland, D.W. (1998) A structural scaffolding of intermediate filaments in health and disease. Science, 279, 514-519.
7. Omary, M.B., Coulombe, P.A. and McLean, W.H.I. (2004) Intermediate filament proteins and their associated diseases. N. Engl. J. Med., 351, 2087-2100.
8. Irvine, A.D. and McLean, W.H.I. (1999) Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br. J. Dermatol., 140, 815-828.
9. Steinert, P.M., Yang, J.M., Bale, S.J. and Compton, J.G. (1993) Concurrence between the molecular overlap regions in keratin intermediate filaments and the locations of keratin mutations in genodermatoses. Biochem. Biophys. Res. Commun., 197, 840-848.
10. Schweizer, J., Langbein, L., Rogers, M.A. and Winter, H. (2007) Hair follicle-specific keratins and their diseases. Exp. Cell Res., 313, 2010-2020.
11. Bonifas, J.M., Rothman, A.L. and Epstein, E.H. (1991) Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Science, 254, 1202-1205.
12. Coulombe, P.A., Hutton, M.E., Letai, A., Hebert, A., Paller, A.S. and Fuchs, E. (1991) Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analysis. Cell, 66, 1301-1311.
13. Lane, E.B., Rugg, E.L., Navsaria, H., Leigh, I.M., Heagerty, A.H.M., Ishida-Yamamoto, A. and Eady, R.A.J. (1992) A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature, 356, 244-246.
14. Szeverenyi, I., Cassidy, A.J., Chung, C.W., Lee, B.T., Common, J.E., Ogg, S.C., Chen, H., Sim, S.Y., Goh, W.L., Ng, K.W. et al. (2008) The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases. Hum. Mutat., 29, 351-360.
15. Rugg, E.L., McLean, W.H.I., Lane, E.B., Pitera, R., McMillan, J.R., Dopping-Hepenstal, P.J.C., Navsaria, H.A., Leigh, I.M. and Eady, R.A.J. (1994) A functional 'knock-out' for human keratin 14. Genes Dev., 8, 2563-2573.
16. Betz, R.C., Planko, L., Eigelshoven, S., Hanneken, S., Pasternack, S.M., Bussow, H., Bogaert, K.V., Wenzel, J., Braun-Falco, M., Rutten, A. et al. (2006) Loss-of-function mutations in the keratin 5 gene lead to Dowling-Degos disease. Am. J. Hum. Genet., 78, 510-519.
17. Frenk, E., Mevorah, B. and Hohl, D. (1993) The Nageli-Franceschetti-Jadassohn syndrome: a hereditary ectodermal defect leading to colloid-amyloid formation in the dermis. Dermatology, 187, 169-173.
18. McLean, W.H., Irvine, A.D., Hamill, K.J., Whittock, N.V., Coleman-Campbell, C.M., Mellerio, J.E., Ashton, G.S., Dopping-Hepenstal, P.J., Eady, R.A., Jamil, T. et al. (2003) An unusual N-terminal deletion of the laminin alpha3a isoform leads to the chronic granulation tissue disorder laryngo-onycho-cutaneous syndrome. Hum. Mol. Genet., 12, 2395-2409.
19. Rothnagel, J.A., Dominey, A.M., Dempsey, L.D., Longley, M.A., Greenhalg, D.A., Gagne, T.A., Huber, M., Frenk, E., Hohl, D. and Roop, D.R. (1992) Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis. Science, 257, 1128-1130.
20. Reis, A., Hennies, H.-C., Langbein, L., Digweed, M., Mischke, D., Drechsler, M., Schröck, E., Royker-Pokora, B., Franke, W.W., Sperling, K. et al. (1994) Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK). Nat. Genet., 6, 174-179.
21. Kremer, H., Zeeuwen, P., McLean, W.H.I., Mariman, E.C.M., Lane, E.B., Vandekerkhof, P.C.M., Ropers, H.H. and Steijlen, P.M. (1994) Ichthyosis bullosa of siemens is caused by mutations in the keratin 2e gene. J. Invest. Dermatol., 103, 286-289.
22. Rothnagel, J.A., Traupe, H., Wojcik, S., Huber, M., Hohl, D., Pittelkow, M.R., Saeki, H., Ishibashi, Y. and Roop, D.R. (1994) Mutations in the rod domain of keratin 2e in patients with ichthyosis bullosa of Siemens. Nat. Genet., 7, 485-490.
23. McLean, W.H.I., Rugg, E.L., Lunny, D.P., Morley, S.M., Lane, E.B., Swensson, O., Dopping-Hepenstal, P.J.C., Griffiths, W.A.D., Eady, R.A.J., Higgins, C. et al. (1995) Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nat. Genet., 9, 273-278.
24. Bowden, P.E., Haley, J.L., Kansky, A., Rothnagel, J.A., Jones, D.O. and Turner, R.J. (1995) Mutation of a type II keratin gene (K6a) in pachyonychia congenita. Nat. Genet., 10, 363-365.
25. Smith, F.J.D., Jonkman, M.F., van Goor, H., Coleman, C., Covello, S.P., Uitto, J. and McLean, W.H.I. (1998) A mutation in human keratin K6b produces a phenocopy of the K17 disorder pachyonychia congenita type 2. Hum. Mol. Genet., 7, 1143-1148.
26. Wilson, N.J., Messenger, A.G., Leachman, S.A., O'Toole, E.A., Lane, E.B., McLean, W.H. and Smith, F.J. (2010) Keratin K6c mutations cause focal palmoplantar keratoderma. J. Invest. Dermatol., 130, 425-429.
27. Winter, H., Rogers, M.A., Gebhardt, M., Wollina, U., Boxall, L., Chitayat, D., Babul-Hirji, R., Stevens, H.P., Zlotogorski, A. and Schweizer, J. (1997) A new mutation in the type II hair cortex keratin hHb1 involved in the inherited hair disorder monilethrix. Hum. Genet., 101, 165-169.
28. Winter, H., Rogers, M.A., Langbein, L., Stevens, H.P., Leigh, I.M., Labreze, C., Roul, S., Taieb, A., Krieg, T. and Schweizer, J. (1997) Mutations in the hair cortex keratin hHb6 cause the inherited hair disease monilethrix. Nat. Genet., 16, 372-374.
29. van Steensel, M.A., Steijlen, P.M., Bladergroen, R.S., Vermeer, M. and van Geel, M. (2005) A missense mutation in the type II hair keratin hHb3 is associated with monilethrix. J. Med. Genet., 42, e19.
30. Naeem, M., Wajid, M., Lee, K., Leal, S.M. and Ahmad, W. (2006) A mutation in the hair matrix and cuticle keratin KRTHB5 gene causes ectodermal dysplasia of hair and nail type. J. Med. Genet., 43, 274-279.
31. Winter, H., Langbein, L., Praetzel, S., Jacobs, M., Rogers, M.A., Leigh, I.M., Tidman, N. and Schweizer, J. (1998) A novel human type II cytokeratin, K6hf, specifically expressed in the companion layer of the hair follicle. J. Invest. Dermatol., 111, 955-962.
32. Winter, H., Schissel, D., Parry, D.A., Smith, T.A., Liovic, M., Birgitte Lane, E., Edler, L., Langbein, L., Jave-Suarez, L.F., Rogers, M.A. et al. (2004) An unusual Ala12Thr polymorphism in the 1A alpha-helical segment of the companion layer-specific keratin K6hf: evidence for a risk factor in the etiology of the common hair disorder pseudofolliculitis barbae. J. Invest. Dermatol., 122, 652-657.
33. McLean, W.H.I. (2004) Close shave for a keratin disorder-K6hf polymorphism linked to Pseudofolliculitis barbae. J. Invest. Dermatol., 122, xi-xiii.
34. Shimomura, Y., Wajid, M., Petukhova, L., Kurban, M. and Christiano, A.M. (2010) Autosomal-dominant woolly hair resulting from disruption of keratin 74 (KRT74), a potential determinant of human hair texture. Am. J. Hum. Genet., 86, 632-638.
35. Leachman, S.A., Hickerson, R.P., Hull, P.R., Smith, F.J.D., Milstone, L.M., Lane, E.B., Bale, S.J., Roop, D.R., McLean, W.H.I. and Kaspar, R.L. (2008) Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita. J. Dermatol. Sci., 51, 151-157.
36. Hickerson, R.P., Smith, F.J.D., Reeves, R.E., Contag, C.H., Leake, D., Leachman, S.A., Milstone, L.M., McLean, W.H.I. and Kaspar, R.L. (2008) Single-nucleotide-specific siRNA targeting in a dominant-negative skin model. J. Invest. Dermatol., 128, 594-605.
37. Atkinson, S.D., McGilligan, V.E., Liao, H., Szeverenyi, I., Smith, F.J., Moore, C.B. and McLean, W.H. (2011) Development of allele-specific therapeutic siRNA for keratin 5 mutations in epidermolysis bullosa simplex. J. Invest. Dermatol. doi: 10.1038/jid.2011.169.
38. Leachman, S.A., Hickerson, R.P., Schwartz, M.E., Bullough, E.E., Hutcherson, S.L., Boucher, K.M., Hansen, C.D., Eliason, M.J., Srivatsa, G.S., Kornbrust, D.J. et al. (2009) First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol. Ther., 18, 442-446.
39. Irvine, A.D., Corden, L.D., Swensson, O., Swensson, B., Moore, J.E., Frazer, D.G., Smith, F.J.D., Knowlton, R.G., Christophers, E., Rochels, R. et al. (1997) Mutations in cornea-specific keratins K3 or K12 cause Meesmann's corneal dystrophy. Nat. Genet., 16, 184-187.
40. Zhao, Y., Gartner, U., Smith, F.J. and McLean, W.H. (2011) Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita. J. Invest. Dermatol., 131, 1045-1052.
41. Lloyd, C., Yu, Q.C., Cheng, J., Turksen, K., Degenstein, L., Hutton, E. and Fuchs, E. (1995) The basal keratin network of stratified squamous epithelia: defining K15 function in the absence of K14. J. Cell Biol., 129, 1329-1344.
42. Kerns, M., DePianto, D., Yamamoto, M. and Coulombe, P.A. (2010) Differential modulation of keratin expression by sulforaphane occurs via Nrf2-dependent and-independent pathways in skin epithelia. Mol. Biol. Cell, 21, 4068-4075.